NYSE:WST
West Pharmaceutical Services Inc Stock News
$377.36
-2.12 (-0.559%)
At Close: Apr 17, 2024
Reasons to Hold West Pharmaceutical (WST) in Your Portfolio Now
08:46am, Wednesday, 17'th Apr 2024
West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.
West to Host First-Quarter 2024 Conference Call
06:00am, Thursday, 11'th Apr 2024
EXTON, Pa. , April 11, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will re
Reasons to Hold West Pharmaceutical (WST) in Your Portfolio Now
01:10pm, Thursday, 14'th Mar 2024
West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.
Strength Seen in West Pharmaceutical (WST): Can Its 5.7% Jump Turn into More Strength?
08:01am, Wednesday, 13'th Mar 2024
West Pharmaceutical (WST) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price i
West to Participate in Upcoming Investor Conferences
04:30pm, Wednesday, 28'th Feb 2024
EXTON, Pa. , Feb. 28, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will pre
Why West Pharma Is Far From Done
11:36pm, Tuesday, 27'th Feb 2024
West Pharmaceutical Services is a global manufacturer specializing in advanced containment and delivery systems for injectable drugs and healthcare products. The company has a strong focus on high-val
West Pharmaceutical (WST) Beats on Q4 Earnings, HVP Drives Sales
02:35pm, Thursday, 15'th Feb 2024
West Pharmaceutical's (WST) fourth-quarter results reflect a strong demand for non-COVID-19 products, especially HVP devices.
West Pharmaceutical Services, Inc. (WST) Q4 2023 Earnings Call Transcript
02:05pm, Thursday, 15'th Feb 2024
West Pharmaceutical Services, Inc. (WST) Q4 2023 Earnings Call Transcript
West Pharmaceutical (WST) Reports Q4 Earnings: What Key Metrics Have to Say
10:31am, Thursday, 15'th Feb 2024
Although the revenue and EPS for West Pharmaceutical (WST) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare wit
West Pharmaceutical Stock Tumbles on Weak 2024 Outlook
10:08am, Thursday, 15'th Feb 2024
The company had warned in recent months that its clients were slowing down their purchasing.
West Pharmaceutical Services (WST) Beats Q4 Earnings Estimates
08:11am, Thursday, 15'th Feb 2024
West Pharmaceutical Services (WST) came out with quarterly earnings of $1.83 per share, beating the Zacks Consensus Estimate of $1.78 per share. This compares to earnings of $1.77 per share a year ago
Medical equipment maker West Pharmaceutical forecasts weak annual results
07:11am, Thursday, 15'th Feb 2024
West Pharmaceutical Services forecast full-year results below analysts' estimates on Thursday after the company missed fourth-quarter revenue expectations, hurt by weak demand for its medical equipmen
BDX or WST: Which Is the Better Value Stock Right Now?
12:41pm, Tuesday, 13'th Feb 2024
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Becton Dickinson (BDX) or West Pharmaceutical Services (WST). But which of these two stocks is more a
What's in Store for West Pharmaceutical (WST) in Q4 Earnings?
10:00am, Tuesday, 13'th Feb 2024
West Pharmaceutical's (WST) fourth-quarter 2023 results are likely to reflect strength in the Proprietary Products business. However, unfavorable currency movements might have hurt the top and bottom
Insights Into West Pharmaceutical (WST) Q4: Wall Street Projections for Key Metrics
10:22am, Monday, 12'th Feb 2024
Get a deeper insight into the potential performance of West Pharmaceutical (WST) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the esti